The Key To HIV: Gilead Sciences, To Develop Drugs For HIV And NASH, Details Inside
With HIV being considered as one of the long dreaded diseases, experts have yet found the appropriate solution to the problem. Until recently, as Gilead Sciences Inc. (GILD) CEO John Milligan started his presentation at the 35th annual J.P. Morgan Healthcare Conference in San Francisco, together with the investors of the said biopharmaceutical company, it was revealed that they will be starting to launch a project that aims to put emphasis on Hepatitis C, NASH and HIV. Authorities have also revealed that the company will be spending as much as $31.6 billion to show their support in putting an end to these diseases.
Gilead Sciences, To Develop Drugs For HIV And NASH
According to reports revealed by Drug Discovery And Development, the money that will be spent will allegedly be used to support 12 new HIV cure research projects. The series of projects are said to be initiated by the country's leading academic institutions, non-profit organizations and community groups from across the globe, which focuses on three key areas namely, translational research, efficacy studies in animal models and community perspectives of HIV cure. Executive Vice President, Research, Gilead Sciences William Lee, PhD, said that considering their experience gained throughout the years in addressing the issue of HIV/AIDS, they highlighted the fact that there is no one-size-fits-all solution. However, it was found that the company is in fact, excited about the potential of these projects and is looking forward to seeing the results and all the learnings that will be incorporated to it.
Meanwhile, as per Investopedia, Milligan is reportedly optimistic about Gilead's HIV product portfolio. However, the current HIV drugs which are making good revenues for Gilead are based on tenofovir disoproxil fumarate (TDF) medication, which Milligan believes is dying out. In line with it, it was found that the company will now be switching its focus into alternative tenofovir alafenamide (TAF)-based HIV drugs, which include Genvoya, Descovey, and Odefsey drugs. Ultimately, authorities from the said company have highly emphasized that they were recently announced as one of the foremost corporate providers of philanthropic support to address HIV/AIDS by the Funders Concerned About AIDS (FCAA) organization.
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
HIV, The Next Target Of Trump Administration
As continuous efforts to eradicate HIV are taking place, why does the Trump administration wanted to halt the treatment that has been started by the previous government? What’s the truth behind claims that if the current US President would push this through, it will kill thousands? Find out what authorities have to say
How Do We Reduce HIV Risk? Here Are Experts' Tips
With the continuous efforts to eradicate one of the world's long dreaded disease, can we really do certain precautionary measures to prevent the risk of HIV? What are the necessary steps to prevent transmission of the disease? Find out what experts have to say
HIV Vaccine Cures Five Patients For Seven Months
New AIDS vaccine developed in Spain have reportedly cured 5 patients, helping them remain virus-free for seven months after taking the treatment. In the study, the treatment allowed the patients to stop taking regular antiretroviral (ARV) drugs to suppress HIV symptoms.
Nanotechnology For HIV: New Technique Shows Promising Results In HIV Treatment
With continuous efforts to eradicate HIV being one of the world's long dreaded disease, how essential does nanotechnology's role can be? What's the truth behind claims that this new technique offers a new hope as it has induced positive results in HIV treatment? Could it be the answer to the disease? Find out what experts have to say
PrEP For HIV: Raising Awareness; Could It Be The Cure For The Disease?
Considering that HIV has been and is still currently is one of the world’s most dreaded diseases, how essential is the use of PrEP? Could it possibly hold the key for cure that a lot of people have been waiting for? What’s the truth behind claims these claims? Find out what health professionals have to say
MORE IN ITECHPOST
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.